………………..Baht Information updated until (date)…………………………………………. 2. Information in detail for supplementing the consideration. 2.1 The business operation of the applicant is under the supervision of the State or
the supervision of the State or the agency authorized to supervise derivatives trading as: □ being licensed to be a derivatives dealer; □ having been registered to be a derivatives dealer; □ being
which mainly increased from new customers in segment of insurance, retail business and increased from the existing customers expanding the services both of the State enterprise sector and Private sector
Fund Any other type, please specify __________________________________________ 6) Is the NRI CIS a sub-fund of an umbrella fund? Yes No If “Yes”, please state the name of the umbrella fund
) Page 3 of 8 Form 35 – NRI CIS 6) Is the NRI CIS a sub-fund of an umbrella fund? Yes No If “Yes”, please state the name of the umbrella fund
expenditure and investment in state enterprises compared to the same period of last year. The reasons are not only regular expenditures according to disbursements that have been accelerated in the previous
สถาน (TURKMENISTAN) โตเกเลา (TOKELAU) โตโก (TOGO) ไต้หวัน (TAIWAN, PROVINCE OF CHINA) ทาจิกิสถาน (TAJIKISTAN) แทนซาเนีย (TANZANIA, UNITED REPUBLIC OF) นครรัฐวาติกัน (HOLY SEE (VATICAN CITY STATE
the case of exercise the Right of Investment in Laemchabang International Ro-Ro Terminal Co., Ltd. ("LRT”) by to the purchase of 29 percent of shares of NYKT International Terminal Co., Ltd. from Nippon
methods of Acquisition/Disposition Remark INTER PHARMA PUBLIC COMPANY LIMITED (IP) Miss NAPAPORN DECHAKARAT Reporter Common Share 05/03/2020 100 4.70 Purchase Link INTER PHARMA PUBLIC COMPANY LIMITED (IP
Hawaii limited partnership ( "Seller Group" ) with a value of not exceeding USD 250 million or not exceeding Baht 7,909 million1 through the purchase of entire 100 percent equity in by a company in the